Pediatric hepatitis-associated aplastic anemia: clinical heterogeneity and transplant outcomes in five patients
Background Hepatitis-associated aplastic anemia (HAAA) is a rare, potentially life-threatening complication of acute hepatitis in children, characterized by pancytopenia and bone marrow failure (BMF). Historically, outcomes were poor, particularly without timely hematopoietic cell transplantation (HCT). Pediatric outcome data for patients with diagnostic delays, atypical presentations, or failed immunosuppressive therapy (IST) remain limited. Methods We performed a retrospective, single-center case series of five children treated for HAAA from 2022 through 2024. Clinical, laboratory, pathologic, genetic, infectious, and transplant data were reviewed through the latest charted follow-up in the source dataset and contextualized through a targeted narrative review of pediatric HAAA literature. Results The cohort included three girls and two boys, with a median age of 3 years (range: 2–13). The median interval from hepatitis onset to severe aplastic anemia (SAA) was 76 days (range: 0–202), and the median interval from SAA diagnosis to HCT was 113 days (range: 98–149). All patients ultimately had marrow cellularity below 5%. All five engrafted; four were alive and transfusion-independent at last follow-up. One patient died from Epstein–Barr virus (EBV)–associated post-transplant lymphoproliferative disorder (PTLD). No graft failure or relapse of aplasia occurred. Conclusion This series illustrates the clinical heterogeneity of pediatric HAAA and the need for early hematology involvement, donor search, supportive care, and coordinated transplant planning. Successful engraftment occurred despite substantial medical complexity and, in one patient, unsuccessful IST. A multidisciplinary approach and HCT readiness remain important and may support favorable outcomes even in delayed or medically complex cases.
Authors
- Candelaria Deimundo Roura (ORCID: https://orcid.org/0009-0009-4129-9102)
- S. Goteti
- P. Blanco
- J. Vagher
- C. Jaramillo
- A. Rayes
- N. Dunford
- L. D. Maese
- B. Devald
- E. S. Doughty
Institutions
- Intermountain Healthcare (US)
- Providence Sacred Heart Medical Center (US)
- Primary Children's Hospital (US)
- University of Utah (US)
- Huntsman Cancer Institute (US)
- University of Utah Health Care (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fimmu.2026.1971728
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00